![Jason Myers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Myers
Direktör/Styrelseledamot på
Venn Biosciences Corp.
Profil
Jason W.
Myers was the founder of ArcherDX LLC, founded in 2013, where the titles held included President, Chief Executive Officer & Director from 2015 to 2020.
Dr. Myers currently serves as Director at Venn Biosciences Corp.
since 2022.
Former positions include Director at Invitae Corp.
from 2020 to 2021; Independent Director at IsoPlexis Corp.
from 2021 to 2023; President & Director at Singular Genomics Systems, Inc.; Chief Executive & Financial Officer, Director at GenapSys, Inc. from 2021 to 2022; Chief Scientific Officer at Universal Display Corp.
from 2013 to 2015; and Chief Scientific Officer at QIAGEN Beverly LLC.
Education includes undergraduate studies at Colorado State University and a doctorate from Stanford University School of Medicine.
Aktiva positioner av Jason Myers
| Företag | Position | Start |
|---|---|---|
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Operates as a life sciences company unlocking the value of glycoproteomic for the development of transformational healthcare solutions by using AI | Direktör/Styrelseledamot | 2022-10-04 |
Tidigare kända positioner av Jason Myers
| Företag | Position | Slut |
|---|---|---|
| ISOPLEXIS CORPORATION | Direktör/Styrelseledamot | 2023-03-21 |
GenapSys, Inc.
 GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic sequencing ecosystem designed to empower academic and clinical research applications | Verkställande Direktör | 2022-09-01 |
| INVITAE CORPORATION | Direktör/Styrelseledamot | 2021-07-05 |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Grundare | 2020-10-02 |
| UNIVERSAL DISPLAY CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2015-01-01 |
Jason Myerss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Universal Display Corp.
 Universal Display Corp. Electronic Production EquipmentElectronic Technology Engages in research, development and commercialization of organic light emitting diode (OLED), technologies and materials | Electronic Technology |
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
GenapSys, Inc.
GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic sequencing ecosystem designed to empower academic and clinical research applications | Commercial Services |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singular Genomics Systems, Inc.
 Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Operates as a life sciences company unlocking the value of glycoproteomic for the development of transformational healthcare solutions by using AI | Health Technology |
